Due to its historical predominant consideration as a gene negatively associated with later life brain diseases, especially AD, APOE and its possible effects on the normal brain development or as a genetic modifier of specific pathologic conditions such as motor-behavioral delay, cerebral palsy, prematurity, and in-utero life brain abnormalities has received little attention until recent times [101]. The gene discussed is APOE; the disease is Alzheimer disease.